General Information
Version
1.01
Revision date
2025-01-14
Product name
acepromazine maleate
Substance name
C19 H22 N2 O S . C4 H4 O4 442.53
CAS No.
3598-37-6
1.2.1 Relevant identified uses
Laboratory use
supplier name
British Pharmacopoeia Commission
Emergency telephone
+44 (0)20 3080 6561
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H336
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Acepromazine Maleate
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed. H315 - Causes skin irritation. H336 - May cause drowsiness or dizziness.
Precautionary statements
P261 - Avoid breathing dust, fume, gas, mist, vapors and spray P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves P312 - Call a POISON CENTER or doctor if you feel unwell P501 - Dispose of contents and container in accordance with local, regional, national, and international regulations as applicable
PBT Substances
& vPvB This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 4 - (H302) Skin irritation Category 2 - (H315) Specific target organ toxicity (single exposure) Category 3 - (H336) Category 3 Target organ effects: Narcotic effects.
